Loading...

Follow Arthritis Broadcast Network - News on Feedspot

Continue with Google
Continue with Facebook
or

Valid
Arthritis Broadcast Network - News
Arthritis Broadcast Network a collaborative public awareness campaign dev..
+
Ask for your rheumatologist’s referral to make an appointment at the clinic! The Surrey Inflammatory Arthritis (IA) Clinic is ..read more
At a presentation at Providence Health Care, ACE presented the senior leadership at Providence Health Care with the Canada’s Best ..read more
Ixekizumab (Taltz) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling ..read more
A recent research titled “Defining Depression and Anxiety in Individuals with Rheumatic Diseases Using Administrative Health Databases: ..read more
Thanks to our growing audience, Arthritis Broadcast Network (ABN) – powered by Arthritis Consumer Experts – has the most videos and ..read more
Do you have moderate to severe plaque psoriasis? We need your valuable input. The Common Drug Review (CDR) is currently welcoming ..read more
Tildrakizumab (Ilumya) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By ..read more
From Arthritis Consumer Experts (“ACE”), greetings of the season. It’s hard to believe this is the 20th year in a row I’ve had the ..read more
Arthritis Consumer Experts: 2019 Year in Review In 2019, Arthritis Consumer Experts (ACE) worked – everyday, all day – to improve ..read more
Arthritis Consumer Experts (ACE) today expressed its support of Alberta Health’s announcement of its biosimilar policy, becoming the ..read more

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview